Table 2 Distribution of HBV genotypes of TDF-treated HIV/HBV co-infected patients
From: HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
Genotype | Heterosexual | IVDU | MSM | Other | Unknown |
|---|---|---|---|---|---|
A | 22 | 3 | 53 | 2 | 2 |
n = 82 (57 %) | |||||
A + D | 1 | 1 | 2 | 0 | 0 |
n = 4 (3 %) | |||||
A + G | 3 | 1 | 11 | 0 | 1 |
n = 16 (11 %) | |||||
B | 1 | 0 | 1 | 0 | 0 |
n = 2 (1 %) | |||||
C | 2 | 0 | 0 | 0 | 0 |
n = 2 (1 %) | |||||
D | 5 | 25 | 4 | 0 | 1 |
n = 35 (24 %) | |||||
E | 2 | 0 | 0 | 0 | 0 |
n = 2 (1 %) | |||||
Total n = 143 | 36 (25 %) | 30 (21 %) | 71(50 %) | 2 (1 %) | 4 (3 %) |